Nucoxia P Tablet is a combination analgesic and anti-inflammatory medication containing Etoricoxib 60 mg and Paracetamol 325 mg. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that provides effective relief from pain and inflammation by blocking the COX-2 enzyme involved in the synthesis of prostaglandins, which are mediators of inflammation and pain. Paracetamol, also known as acetaminophen, is an analgesic and antipyretic agent that acts centrally to reduce pain and fever. The combination of these two active ingredients offers synergistic effects, making Nucoxia P Tablet suitable for managing acute musculoskeletal pain, osteoarthritis, rheumatoid arthritis, and other inflammatory conditions. It is particularly beneficial in patients requiring potent pain relief with a lower risk of gastrointestinal side effects compared to non-selective NSAIDs, due to Etoricoxib’s COX-2 selectivity. Nucoxia P should be used under medical supervision, with caution advised in patients with a history of cardiovascular disease, hepatic or renal impairment, or hypersensitivity to any component. The dosage and duration of therapy should be individualized based on clinical response and tolerability. Common adverse effects may include gastrointestinal discomfort, headache, dizziness, and elevated liver enzymes. Patients are advised to report any unusual symptoms promptly to their healthcare provider.